{"id":2247,"date":"2021-11-23T00:00:00","date_gmt":"2021-11-23T00:00:00","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/2247"},"modified":"2021-11-23T00:00:00","modified_gmt":"2021-11-23T00:00:00","slug":"centogene%e6%93%b4%e5%a4%a7%e8%88%87agios%e7%9a%84%e5%90%88%e4%bd%9c%ef%bc%8c%e4%bb%a5%e6%9c%9f%e5%9c%a8%e7%bd%95%e8%a6%8b%e8%a1%80%e6%b6%b2%e7%96%be%e7%97%85%e9%a0%98%e5%9f%9f%e7%8d%b2%e5%be%97","status":"publish","type":"post","link":"https:\/\/www.centogene.com\/tw\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/","title":{"rendered":"Centogene\u64f4\u5927\u8207Agios\u7684\u5408\u4f5c\uff0c\u4ee5\u671f\u5728\u7f55\u898b\u8840\u6db2\u75be\u75c5\u9818\u57df\u7372\u5f97\u65b0\u7684\u898b\u89e3"},"content":{"rendered":"

\u7f8e\u570b\u9ebb\u85a9\u8af8\u585e\u5dde\u528d\u6a4b\u3001\u5fb7\u570b\u7f85\u65af\u6258\u514b\u548c\u67cf\u6797\uff0c2021\u5e7411\u67084\u65e5\uff08GLOBE NEWSWIRE\uff09\u2014\u5c08\u6ce8\u65bc\u5229\u7528\u6578\u64da\u9a45\u52d5\u6d1e\u5bdf\u8a3a\u65b7\u3001\u7406\u89e3\u548c\u6cbb\u7642\u7f55\u898b\u75be\u75c5\u7684\u5546\u696d\u5316\u968e\u6bb5\u516c\u53f8Centogene NV\uff08\u7d0d\u65af\u9054\u514b\u80a1\u7968\u4ee3\u78bc\uff1aCNTG\uff09\u4eca\u65e5\u5ba3\u5e03\uff0c\u5df2\u64f4\u5927\u8207AgAg Pharmaceuticals, Inc.\uff08\u7d0d\u65af\u9054\u514b\u80a1\u7968\u4ee3\u78bc\uff1aCNTG\uff09\u4eca\u65e5\u5ba3\u5e03\uff0c\u5df2\u64f4\u5927\u8207AgAg Pharmaceuticals, Inc.\uff08\u7d0d\u65af\u9054\u514b\u80a1\u7968\u4ee3\u78bc\uff1aAGIO\uff09\u7684\u5408\u4f5c\u80a1\u7968\u4ee3\u78bc\u3002 Agios Pharmaceuticals, Inc.\u662f\u7d30\u80de\u4ee3\u8b1d\u9818\u57df\u7684\u9818\u5c0e\u8005\uff0c\u81f4\u529b\u65bc\u958b\u767c\u548c\u63d0\u4f9b\u91dd\u5c0d\u57fa\u56e0\u660e\u78ba\u75be\u75c5\u7684\u5275\u65b0\u7642\u6cd5\u3002\u6839\u64da\u65b0\u5354\u8b70\uff0cCENTOGENE\u5c07\u70baAgios\u7684\u4e09\u9805\u5168\u7403\u95dc\u9375\u6027\u8a66\u9a57\u63d0\u4f9b\u57fa\u56e0\u6aa2\u6e2c\u548c\u81e8\u5e8a\u8a66\u9a57\u652f\u6301\uff0c\u9019\u4e9b\u8a66\u9a57\u5206\u5225\u91dd\u5c0d\u5730\u4e2d\u6d77\u8ca7\u8840\u548c\u942e\u72c0\u7d30\u80de\u8ca7\u8840\u3002\u5148\u524d\uff0cCENTOGENE\u5df2\u70baAgios\u7684\u4e19\u916e\u9178\u6fc0\u9176\uff08\u300cPK\u300d\uff09\u7f3a\u4e4f\u75c7\u81e8\u5e8a\u8a08\u756b\u63d0\u4f9b\u652f\u6301\u3002.<\/p>\n

\u96d9\u65b9\u7c3d\u7f72\u4e86\u70ba\u671f\u4e09\u5e74\u7684\u5546\u696d\u670d\u52d9\u4ed8\u8cbb\u5354\u8b70\u3002 Agios\u5c07\u8ca0\u8cac\u5354\u8abf\u4e26\u627f\u64d4\u76f8\u95dc\u9805\u76ee\u7684\u8cbb\u7528\uff1b\u66f4\u591a\u8ca1\u52d9\u7d30\u7bc0\u672a\u4e88\u63ed\u9732\u3002\u6b64\u6b21\u5408\u4f5c\u5c07\u70ba\u60a3\u8005\u63d0\u4f9b\u57fa\u56e0\u6aa2\u6e2c\u670d\u52d9\uff0c\u4ee5\u5e6b\u52a9\u8b58\u5225\u81f4\u75c5\u7a81\u8b8a\uff0c\u5305\u62ecHBA1\u3001HBA2\u548cHBB\u57fa\u56e0\u3002 Agios\u7684\u5168\u7403\u81e8\u5e8a\u8a66\u9a57\u5c07\u5728\u5317\u7f8e\u3001\u6b50\u6d32\u3001\u4e2d\u6771\u548c\u5317\u975e\u3001\u4e9e\u592a\u4ee5\u53ca\u62c9\u4e01\u7f8e\u6d32\u62db\u52df\u75c5\u60a3\u3002\u6a23\u672c\u5c07\u4f7f\u7528CENTOGENE\u5c08\u6709\u7684CentoCard\u00ae\u9032\u884c\u4e7e\u8840\u6591\u5206\u6790\u3002.<\/p>\n

\u9019\u9805\u5408\u4f5c\u95dc\u4fc2\u7684\u95dc\u9375\u8cc7\u7522\u662f CENTOGENE \u7368\u7279\u7684\u4ee5\u7f55\u898b\u75be\u75c5\u70ba\u4e2d\u5fc3\u7684\u751f\u7269\u8cc7\u6599\u5eab\uff0c\u8a72\u8cc7\u6599\u5eab\u65e8\u5728\u52a0\u901f\u7cbe\u6e96\u8a3a\u65b7\uff0c\u4e26\u4e0d\u65b7\u6df1\u5165\u4e86\u89e3\u5c0e\u81f4\u7f55\u898b\u75be\u75c5\u7684\u907a\u50b3\u56e0\u7d20\u3002.<\/p>\n

\u201c\u300c\u6191\u85c9\u6211\u5011\u5168\u7403\u9818\u5148\u7684\u7f55\u898b\u75be\u75c5\u751f\u7269\u8cc7\u6599\u5eab\uff0c\u6211\u5011\u662f\u7f55\u898b\u75be\u75c5\u6cbb\u7642\u85e5\u7269\u767c\u73fe\u548c\u958b\u767c\u9818\u57df\u7684\u9996\u9078\u5408\u4f5c\u5925\u4f34\u3002\u6211\u5011\u4ee5\u6578\u64da\u70ba\u9a45\u52d5\u7684\u6d1e\u5bdf\u529b\u80fd\u5920\u52a0\u901f\u81e8\u5e8a\u8a66\u9a57\u4e26\u964d\u4f4e\u5176\u98a8\u96aa\uff0c\u300dCENTOGENE\u57f7\u884c\u9577Andrin Oswald\u91ab\u5b78\u535a\u58eb\u8868\u793a\u3002 \u300c\u7d50\u5408CENTOGENE\u5728\u907a\u50b3\u5b78\u9818\u57df\u7684\u5c08\u696d\u77e5\u8b58\u548c\u7368\u7279\u7684\u5168\u7403\u6d1e\u5bdf\u529b\uff0c\u5c07\u6709\u52a9\u65bc\u6211\u5011\u66f4\u597d\u5730\u4e86\u89e3\u9019\u4e9b\u7f55\u898b\u75be\u75c5\u7684\u75be\u75c5\u751f\u7269\u5b78\u3002\u6b64\u6b21\u5408\u4f5c\u5c07\u652f\u6301Agios\u516c\u53f8\u9996\u5275\u7684PK\u6fc0\u6d3b\u5291\u7684\u7814\u767c\uff0c\u4f7f\u5176\u6210\u70ba\u5730\u4e2d\u6d77\u8ca7\u8840\u548c\u942e\u72c0\u7d30\u80de\u8ca7\u8840\u7684\u6f5b\u5728\u7642\u6cd5\u3002\u9019\u5169\u7a2e\u75be\u75c5\u7684\u60a3\u8005\u7fa4\u9ad4\u76ee\u524d\u90fd\u7f3a\u4e4f\u6cbb\u7642\u9078\u64c7\uff0c\u4e9f\u9700\u65b0\u7684\u6cbb\u7642\u65b9\u6848\u3002\u300d\u201d<\/p>\n

\u201c\u300c\u5c55\u671b\u4eca\u5e74\u5e74\u5e95\u524d\u555f\u52d5\u7684\u4e09\u9805\u91dd\u5c0d\u5730\u4e2d\u6d77\u8ca7\u8840\u548c\u942e\u72c0\u7d30\u80de\u75c5\u7684\u95dc\u9375\u6027\u5168\u7403\u81e8\u5e8a\u8a66\u9a57\uff0c\u6211\u5011\u5f88\u9ad8\u8208\u80fd\u8207CENTOGENE\u64f4\u5927\u5408\u4f5c\uff0c\u4ee5\u66f4\u597d\u5730\u4e86\u89e3\u6211\u5011\u7814\u7a76\u4e2d\u60a3\u8005\u7684\u6f5b\u5728\u907a\u50b3\u56e0\u7d20\u4ee5\u53ca\u6211\u5011\u6b63\u5728\u7814\u767c\u7684\u85e5\u7269\u7684\u6f5b\u5728\u5f71\u97ff\uff0c\u300dAgios\u9996\u5e2d\u91ab\u7642\u5b98Sarah Gheuens\u91ab\u5b78\u535a\u58eb\u8868\u793a\u3002 \u201d\u5728Agios\uff0c\u6211\u5011\u6df1\u77e5\u5353\u8d8a\u7684\u79d1\u5b78\u7814\u7a76\u9700\u8981\u4e16\u754c\u4e00\u6d41\u7684\u5718\u968a\u5408\u4f5c\u3002\u900f\u904e\u8207CENTOGENE\u9019\u6a23\u5091\u51fa\u7684\u5408\u4f5c\u5925\u4f34\u651c\u624b\uff0c\u6211\u5011\u53ef\u4ee5\u5171\u540c\u52a0\u901f\u5275\u65b0\uff0c\u5f9e\u800c\u70ba\u60a3\u8005\u7684\u751f\u6d3b\u5e36\u4f86\u7a4d\u6975\u7684\u6539\u8b8a\u3002\u201c<\/p>\n

\u8a72\u5354\u8b70\u6a19\u8a8c\u8457 CENTOGENE \u5728\u672a\u4f86 10 \u5e74\u5167\u6cbb\u6108 100 \u7a2e\u7f55\u898b\u75be\u75c5\u7684\u4f7f\u547d\u53c8\u9081\u51fa\u4e86\u91cd\u8981\u4e00\u6b65\u3002. <\/p>\n

\u4e86\u89e3\u66f4\u591a<\/a><\/p>\n

\u95dc\u65bc\u5730\u4e2d\u6d77\u8ca7\u8840<\/h2>\n

\u5730\u4e2d\u6d77\u8ca7\u8840\u662f\u4e00\u7a2e\u907a\u50b3\u6027\u8840\u6db2\u75be\u75c5\uff0c\u5728\u7f8e\u570b\u3001\u6cd5\u570b\u3001\u5fb7\u570b\u3001\u7fa9\u5927\u5229\u3001\u897f\u73ed\u7259\u548c\u82f1\u570b\uff08\u300c\u6b50\u76df\u4e94\u570b\u300d\uff09\u7d04\u670918,000\u81f323,000\u4eba\u60a3\u6709\u6b64\u75c5\uff0c\u4e16\u754c\u5176\u4ed6\u5730\u5340\u9084\u6709\u66f4\u591a\u60a3\u8005\u3002\u8840\u7d05\u86cb\u767d\u57fa\u56e0\u7684\u907a\u50b3\u6027\u7a81\u8b8a\u5c0e\u81f4\u4eba\u9ad4\u7522\u751f\u7684\u8840\u7d05\u86cb\u767d\u5c11\u65bc\u6b63\u5e38\u6c34\u5e73\uff0c\u800c\u8840\u7d05\u86cb\u767d\u5c0d\u65bc\u7d05\u8840\u7403\u651c\u5e36\u6c27\u6c23\u81f3\u95dc\u91cd\u8981\uff0c\u56e0\u6b64\u6703\u5c0e\u81f4\u56b4\u91cd\u7684\u8ca7\u8840\u53ca\u76f8\u95dc\u4f75\u767c\u75c7\u3002.<\/p>\n

\u5730\u4e2d\u6d77\u578b\u8ca7\u8840\u5206\u70ba\u03b2\u578b\u548c\u03b1\u578b\u5169\u7a2e\u3002\u5169\u8005\u5747\u70ba\u9ad4\u67d3\u8272\u9ad4\u96b1\u6027\u907a\u50b3\uff0c\u5168\u7403\u7d04\u670951%\u7684\u4eba\u53e3\u5e36\u6709\u03b2\u6216\u03b1\u73e0\u86cb\u767d\u57fa\u56e0\u7a81\u8b8a\u3002\u90e8\u5206\u60a3\u8005\u9700\u8981\u9577\u671f\u8f38\u8840\uff0c\u53ef\u80fd\u5c0e\u81f4\u9435\u904e\u91cf\u53ca\u76f8\u95dc\u5668\u5b98\u640d\u50b7\u7b49\u9577\u671f\u4f75\u767c\u75c7\u3002\u5373\u4f7f\u7121\u9700\u9577\u671f\u8f38\u8840\u7684\u60a3\u8005\uff0c\u4e5f\u53ef\u80fd\u51fa\u73fe\u80ba\u52d5\u8108\u9ad8\u58d3\u548c\u8840\u6813\u5f62\u6210\u7b49\u56b4\u91cd\u4f75\u767c\u75c7\u3002.<\/p>\n

\u8fd1\u5e74\u4f86\uff0c\u03b2-\u5730\u4e2d\u6d77\u8ca7\u8840\u7684\u6cbb\u7642\u53d6\u5f97\u4e86\u4e00\u4e9b\u9032\u5c55\uff1b\u7136\u800c\uff0c\u4ecd\u6709\u672a\u88ab\u6eff\u8db3\u7684\u9700\u6c42\uff0c\u9700\u8981\u9032\u4e00\u6b65\u4e86\u89e3\u8a72\u75be\u75c5\u4e26\u958b\u767c\u66f4\u591a\u6cbb\u7642\u65b9\u6848\u3002\u76ee\u524d\u5c1a\u7121\u6838\u51c6\u7684\u03b1-\u5730\u4e2d\u6d77\u578b\u8ca7\u8840\u6cbb\u7642\u65b9\u6cd5\u3002.<\/p>\n

\u95dc\u65bc\u942e\u72c0\u7d30\u80de\u75be\u75c5<\/h3>\n

\u942e\u72c0\u7d30\u80de\u75be\u75c5\u662f\u4e00\u7a2e\u907a\u50b3\u6027\u7d05\u8840\u7403\u75be\u75c5\uff0c\u5728\u7f8e\u570b\u548c\u6b50\u76df\u4e94\u570b\u7d04\u670912\u842c\u81f313.5\u842c\u4eba\u53d7\u5176\u5f71\u97ff\uff0c\u4e16\u754c\u5176\u4ed6\u5730\u5340\u9084\u6709\u66f4\u591a\u60a3\u8005\u3002\u942e\u72c0\u7d30\u80de\u75be\u75c5\u662f\u7531\u4e00\u7a2e\u7a81\u8b8a\u7684\u8840\u7d05\u86cb\u767d\u5f15\u8d77\u7684\uff0c\u9019\u7a2e\u7a81\u8b8a\u7684\u8840\u7d05\u7d20\u6703\u963b\u585e\u8840\u7ba1\u3002\u56e0\u6b64\uff0c\u8840\u6db2\u7121\u6cd5\u6b63\u5e38\u6d41\u52d5\uff0c\u9019\u53ef\u80fd\u5c0e\u81f4\u5287\u70c8\u75bc\u75db\u548c\u5668\u5b98\u640d\u50b7\u3002.<\/p>\n

\u942e\u72c0\u7d30\u80de\u75be\u75c5\u6703\u5f15\u767c\u591a\u7a2e\u56b4\u91cd\u4f75\u767c\u75c7\uff0c\u5305\u62ec\u611f\u67d3\u3001\u6025\u6027\u80f8\u75db\u75c7\u5019\u7fa4\u548c\u4e2d\u98a8\uff0c\u4e26\u53ef\u80fd\u5c0e\u81f4\u58fd\u547d\u7e2e\u77ed\u3002\u5118\u7ba1\u8fd1\u5e74\u4f86\u7814\u7a76\u548c\u81e8\u5e8a\u9032\u5c55\u53d6\u5f97\u4e86\u986f\u8457\u6210\u6548\uff0c\u76ee\u524d\u5df2\u6709\u591a\u7a2e\u6cbb\u7642\u65b9\u6848\u53ef\u4f9b\u9078\u64c7\uff1b\u7136\u800c\uff0c\u60a3\u8005\u4ecd\u7136\u98fd\u53d7\u6025\u6027\u548c\u6162\u6027\u75bc\u75db\u4ee5\u53ca\u56b4\u91cd\u4f75\u767c\u75c7\u7684\u56f0\u64fe\uff0c\u56e0\u6b64\u4e9f\u9700\u9032\u4e00\u6b65\u7684\u6cbb\u7642\u7a81\u7834\u3002.<\/p>\n

\u95dc\u65bcPK\u7f3a\u4e4f\u75c7<\/h3>\n

\u4e19\u916e\u9178\u6fc0\u9176\uff08PK\uff09\u7f3a\u4e4f\u75c7\u662f\u4e00\u7a2e\u7f55\u898b\u7684\u907a\u50b3\u6027\u75be\u75c5\uff0c\u8868\u73fe\u70ba\u6162\u6027\u6eb6\u8840\u6027\u8ca7\u8840\uff0c\u5373\u7d05\u8840\u7403\u52a0\u901f\u7834\u58de\u3002 PKLR\u57fa\u56e0\u7684\u907a\u50b3\u7a81\u8b8a\u5c0e\u81f4\u7d05\u8840\u7403\u5167\u7d30\u80de\u80fd\u91cf\u4e0d\u8db3\uff0c\u8868\u73fe\u70baPKR\u9176\u6d3b\u6027\u964d\u4f4e\u3001\u4e09\u78f7\u9178\u817a\u82f7\uff08ATP\uff09\u6c34\u5e73\u4e0b\u964d\u4ee5\u53ca\u4e0a\u6e38\u4ee3\u8b1d\u7269\uff08\u5305\u62ec2,3-\u4e8c\u78f7\u9178\u7518\u6cb9\u9178\uff082,3-DPG\uff09\uff09\u7684\u7d2f\u7a4d\u3002.<\/p>\n

\u5728\u7f8e\u570b\u548c\u6b50\u76df5\u570b\uff0c\u5927\u7d04\u67093000-8000\u4eba\u60a3\u6709PK\u7f3a\u4e4f\u75c7\u3002 PK\u7f3a\u4e4f\u75c7\u53ef\u80fd\u5c0e\u81f4\u56b4\u91cd\u7684\u4f75\u767c\u75c7\uff0c\u5982\u80ba\u52d5\u8108\u9ad8\u58d3\u3001\u9ad3\u5916\u9020\u8840\u548c\u9aa8\u8cea\u758f\u9b06\u75c7\u3002.<\/p>\n

\u76ee\u524d\u5c1a\u7121\u6838\u51c6\u7684PK\u7f3a\u4e4f\u75c7\u75be\u75c5\u6539\u5584\u7642\u6cd5\u3002.<\/p>\n

\u5982\u9700\u4e86\u89e3\u66f4\u591a\u95dc\u65bc\u6b63\u5728\u9032\u884c\u7684\u81e8\u5e8a\u8a66\u9a57\u7684\u4fe1\u606f<\/a><\/p>\n

\u95dc\u65bc\u963f\u5409\u5967\u65af<\/h3>\n

Agios \u81f4\u529b\u65bc\u900f\u904e\u5728\u7d30\u80de\u4ee3\u8b1d\u9818\u57df\u7684\u79d1\u5b78\u9818\u5148\u5730\u4f4d\uff0c\u767c\u73fe\u548c\u958b\u9aee\u7528\u65bc\u6cbb\u7642\u57fa\u56e0\u76f8\u95dc\u75be\u75c5\u7684\u65b0\u578b\u7814\u7a76\u6027\u85e5\u7269\u3002\u8a72\u516c\u53f8\u76ee\u524d\u6700\u5148\u9032\u7684\u5019\u9078\u85e5\u7269\u662f\u9996\u5275\u7684\u4e19\u916e\u9178\u6fc0\u9176 R (PKR) \u6d3b\u5316\u5291 mitapivat\uff0c\u76ee\u524d\u6b63\u5728\u8a55\u4f30\u5176\u6cbb\u7642\u4e09\u7a2e\u4e0d\u540c\u6eb6\u8840\u6027\u8ca7\u8840\u7684\u7642\u6548\u3002\u9664\u4e86\u6d3b\u8e8d\u7684\u5f8c\u671f\u81e8\u5e8a\u7814\u767c\u7ba1\u7dda\u5916\uff0cAgios \u9084\u64c1\u6709\u591a\u500b\u8655\u65bc\u81e8\u5e8a\u548c\u81e8\u5e8a\u524d\u958b\u767c\u968e\u6bb5\u7684\u65b0\u578b\u7814\u7a76\u6027\u7642\u6cd5\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554f[\u6b64\u8655\u63d2\u5165\u93c8\u63a5]\u3002 \u516c\u53f8\u7db2\u7ad9<\/a>.<\/p>\n

\u95dc\u65bc CENTOGENE<\/h4>\n

CENTOGENE\u81f4\u529b\u65bc\u7f55\u898b\u75be\u75c5\u7684\u8a3a\u65b7\u548c\u7814\u7a76\uff0c\u900f\u904e\u8f49\u5316\u771f\u5be6\u4e16\u754c\u7684\u81e8\u5e8a\u3001\u907a\u50b3\u548c\u591a\u7d44\u5b78\u6578\u64da\uff0c\u5be6\u73fe\u7f55\u898b\u75be\u75c5\u7684\u8a3a\u65b7\u3001\u7406\u89e3\u548c\u6cbb\u7642\u3002\u6211\u5011\u7684\u76ee\u6a19\u662f\u5229\u7528\u6211\u5011\u8c50\u5bcc\u7684\u7f55\u898b\u75be\u75c5\u77e5\u8b58\u548c\u6578\u64da\uff0c\u70ba\u6cbb\u7642\u6c7a\u7b56\u63d0\u4f9b\u5408\u7406\u7684\u4f9d\u64da\uff0c\u4e26\u52a0\u901f\u65b0\u578b\u5b64\u5152\u85e5\u7684\u7814\u767c\u3002 CENTOGENE\u5df2\u958b\u767c\u51fa\u4e00\u500b\u5168\u7403\u5c08\u6709\u7684\u7f55\u898b\u75be\u75c5\u5e73\u53f0\uff0c\u8a72\u5e73\u53f0\u57fa\u65bc\u6211\u5011\u64c1\u6709\u8d85\u904e39\u5104\u500b\u52a0\u6b0a\u6578\u64da\u9ede\u7684\u771f\u5be6\u4e16\u754c\u6578\u64da\u5b58\u5132\u5eab\uff0c\u9019\u4e9b\u6578\u64da\u9ede\u4f86\u81ea\u7d0460\u842c\u540d\u60a3\u8005\uff0c\u6db5\u84cb120\u591a\u500b\u570b\u5bb6\u3002.<\/p>\n

\u516c\u53f8\u5e73\u53f0\u5305\u542b\u53cd\u6620\u5168\u7403\u4eba\u53e3\u7684\u6d41\u884c\u75c5\u5b78\u3001\u8868\u578b\u548c\u907a\u50b3\u6578\u64da\uff0c\u4ee5\u53ca\u60a3\u8005\u8840\u6db2\u6a23\u672c\u548c\u7d30\u80de\u57f9\u990a\u7684\u751f\u7269\u6a23\u672c\u5eab\u3002 CENTOGENE \u8a8d\u70ba\uff0c\u9019\u662f\u76ee\u524d\u552f\u4e00\u5c08\u6ce8\u65bc\u5c0d\u591a\u5c64\u6b21\u8cc7\u6599\u9032\u884c\u5168\u9762\u5206\u6790\u4ee5\u589e\u9032\u5c0d\u7f55\u898b\u907a\u50b3\u75be\u75c5\u7406\u89e3\u7684\u5e73\u53f0\u3002\u8a72\u5e73\u53f0\u80fd\u5920\u66f4\u597d\u5730\u8b58\u5225\u548c\u5206\u5c64\u60a3\u8005\u53ca\u5176\u6f5b\u5728\u75be\u75c5\uff0c\u5f9e\u800c\u4fc3\u9032\u548c\u52a0\u901f\u5b64\u5152\u85e5\u7684\u767c\u73fe\u3001\u958b\u767c\u548c\u61c9\u7528\u3002\u622a\u81f3 2020 \u5e74 12 \u6708 31 \u65e5\uff0c\u672c\u516c\u53f8\u5df2\u8207 30 \u591a\u5bb6\u88fd\u85e5\u516c\u53f8\u5408\u4f5c\u3002.<\/p>\n

\u95dc\u6ce8\u6211\u5011 \u5630\u5630\u55b3\u55b3 <\/a>| Facebook <\/a>| LinkedIn <\/a>| Youtube<\/a><\/p>\n

\u524d\u77bb\u6027\u8072\u660e<\/h4>\n

\u672c\u65b0\u805e\u7a3f\u5305\u542b\u7f8e\u570b\u806f\u90a6\u8b49\u5238\u6cd5\u610f\u7fa9\u4e0a\u7684\u300c\u524d\u77bb\u6027\u9673\u8ff0\u300d\u3002\u672c\u65b0\u805e\u7a3f\u4e2d\u975e\u6b77\u53f2\u4e8b\u5be6\u7684\u9673\u8ff0\u5747\u70ba\u524d\u77bb\u6027\u9673\u8ff0\uff0c\u8af8\u5982\u300c\u9810\u671f\u300d\u3001\u300c\u76f8\u4fe1\u300d\u3001\u300c\u7e7c\u7e8c\u300d\u3001\u300c\u671f\u671b\u300d\u3001\u300c\u4f30\u8a08\u300d\u3001\u300c\u6253\u7b97\u300d\u3001\u300c\u9810\u8a08\u300d\u7b49\u8a5e\u8a9e\u4ee5\u53ca\u985e\u4f3c\u8868\u9054\u548c\u8868\u793a\u5c07\u4f86\u6642\u6216\u689d\u4ef6\u7684\u52d5\u8a5e\uff0c\u4f8b\u5982\u300c\u5c07\u300d\u3001\u300c\u6703\u300d\u3001\u300c\u61c9\u8a72\u300d\u3001\u300c\u53ef\u80fd\u300d\u3001\u300c\u6216\u8a31\u300d\u3001\u300c\u53ef\u4ee5\u300d\u7b49\uff0c\u901a\u5e38\u7528\u65bc\u8b58\u5225\u524d\u77bb\u6027\u9673\u8ff0\u3002\u6b64\u985e\u524d\u77bb\u6027\u9673\u8ff0\u6d89\u53ca\u5df2\u77e5\u548c\u672a\u77e5\u7684\u98a8\u96aa\u3001\u4e0d\u78ba\u5b9a\u6027\u4ee5\u53ca\u5176\u4ed6\u91cd\u8981\u56e0\u7d20\uff0c\u9019\u4e9b\u56e0\u7d20\u53ef\u80fd\u5c0e\u81f4CENTOGENE\u7684\u5be6\u969b\u696d\u7e3e\u3001\u8868\u73fe\u6216\u6210\u5c31\u8207\u524d\u77bb\u6027\u9673\u8ff0\u4e2d\u660e\u793a\u6216\u6697\u793a\u7684\u4efb\u4f55\u672a\u4f86\u696d\u7e3e\u3001\u8868\u73fe\u6216\u6210\u5c31\u5b58\u5728\u91cd\u5927\u5dee\u7570\u3002\u6b64\u985e\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\uff1a\u5168\u7403\u7d93\u6fdf\u60c5\u52e2\u60e1\u5316\u4ee5\u53ca\u5168\u7403\u91d1\u878d\u5e02\u5834\u6301\u7e8c\u4e0d\u7a69\u5b9a\u548c\u6ce2\u52d5\uff1b\u65b0\u51a0\u75ab\u60c5\u5c0d\u6211\u5011\u7684\u696d\u52d9\u548c\u7d93\u71df\u696d\u7e3e\u7684\u5f71\u97ff\uff1b\u73fe\u884c\u548c\u64ec\u8b70\u7684\u6cd5\u5f8b\u3001\u6cd5\u898f\u548c\u653f\u5e9c\u653f\u7b56\u53ef\u80fd\u767c\u751f\u7684\u8b8a\u5316\uff1b\u884c\u696d\u7af6\u722d\u52a0\u5287\u548c\u6574\u5408\u5e36\u4f86\u7684\u58d3\u529b\uff1b\u76e3\u7ba1\u5be9\u6279\uff08\u5305\u62ec\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\u7684\u5be9\u6279\uff09\u7684\u8cbb\u7528\u548c\u4e0d\u78ba\u5b9a\u6027\uff1b\u6211\u5011\u5c0d\u7b2c\u4e09\u65b9\u548c\u5408\u4f5c\u5925\u4f34\u7684\u4f9d\u8cf4\uff08\u5305\u62ec\u6211\u5011\u7ba1\u7406\u6210\u9577\u548c\u5efa\u7acb\u65b0\u5ba2\u6236\u95dc\u4fc2\u7684\u80fd\u529b\uff09\uff1b\u6211\u5011\u5c0d\u7f55\u898b\u75be\u75c5\u884c\u696d\u7684\u4f9d\u8cf4\uff1b\u6211\u5011\u7ba1\u7406\u570b\u969b\u64f4\u5f35\u7684\u80fd\u529b\uff1b\u6211\u5011\u5c0d\u95dc\u9375\u4eba\u54e1\u7684\u4f9d\u8cf4\uff1b\u6211\u5011\u5c0d\u77e5\u8b58\u7522\u6b0a\u4fdd\u8b77\u7684\u4f9d\u8cf4\uff1b\u532f\u7387\u6216\u5176\u4ed6\u56e0\u7d20\u5c0e\u81f4\u7684\u7d93\u71df\u696d\u7e3e\u6ce2\u52d5\u3002\u6709\u95dc\u53ef\u80fd\u5c0e\u81f4\u5be6\u969b\u7d50\u679c\u8207\u9019\u4e9b\u524d\u77bb\u6027\u8072\u660e\u4e2d\u6240\u8868\u9054\u7684\u7d50\u679c\u5b58\u5728\u5dee\u7570\u7684\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\uff0c\u4ee5\u53ca\u8207CENTOGENE\u696d\u52d9\u76f8\u95dc\u7684\u7e3d\u9ad4\u98a8\u96aa\u7684\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u53c3\u95b1CENTOGENE\u65bc2021\u5e744\u670815\u65e5\u5411\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08\u201cSEC\u201d\uff09\u63d0\u4ea4\u768420-F\u8868\u683c\u53ca\u5176\u5f8c\u7e8c\u6587\u4ef6\u4e2d\u5217\u51fa\u7684CENTOGENE\u98a8\u96aa\u56e0\u7d20\u3002\u672c\u65b0\u805e\u7a3f\u4e2d\u5305\u542b\u7684\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u50c5\u4ee3\u8868\u622a\u81f3\u672c\u65b0\u805e\u7a3f\u767c\u5e03\u4e4b\u65e5\u7684\u4fe1\u606f\uff0cCENTOGENE\u660e\u78ba\u8072\u660e\u4e0d\u627f\u64d4\u4efb\u4f55\u66f4\u65b0\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u7684\u7fa9\u52d9\uff0c\u7121\u8ad6\u662f\u56e0\u70ba\u65b0\u8cc7\u8a0a\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u3002.<\/p>\n

\u5a92\u9ad4\u806f\u7d61\u4eba\uff1a<\/h5>\n

\u4e2d\u5fc3\u57fa\u56e0
\u672c\u00b7\u840a\u683c
\u4f01\u696d\u50b3\u64ad\u90e8
Ben.Legg(at)centogene(dot)com<\/a><\/p>\n

\u502b\u7d0d\u7279\u00b7\u65af\u7279\u8cf4\u8c9d\u723e
\u6295\u8cc7\u4eba\u95dc\u4fc2
investor.relations(at)centogene(dot)com<\/a><\/p>\n

FTI\u9867\u554f\u516c\u53f8
\u7f85\u4f2f\u7279\u00b7\u65af\u5766\u5c3c\u65af\u62c9\u7f85
robert.stanislaro(at)fticonsulting(dot)com <\/a><\/p>\n

\u745e\u79cb\u00b7\u514b\u840a\u66fc
rachel.kleiman(at)fticonsulting(dot)com <\/a><\/p>","protected":false},"excerpt":{"rendered":"

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, November 4, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2247","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"\nCENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/tw\/centogene\u64f4\u5927\u8207agios\u7684\u5408\u4f5c\uff0c\u4ee5\u671f\u5728\u7f55\u898b\u8840\u6db2\u75be\u75c5\u9818\u57df\u7372\u5f97\/\" \/>\n<meta property=\"og:locale\" content=\"zh_TW\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases | CENTOGENE\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, November 4, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/tw\/centogene\u64f4\u5927\u8207agios\u7684\u5408\u4f5c\uff0c\u4ee5\u671f\u5728\u7f55\u898b\u8840\u6db2\u75be\u75c5\u9818\u57df\u7372\u5f97\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-23T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admincg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005:\" \/>\n\t<meta name=\"twitter:data1\" content=\"admincg\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9810\u4f30\u95b1\u8b80\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 \u5206\u9418\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\\\/\"},\"author\":{\"name\":\"admincg\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\"},\"headline\":\"CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases\",\"datePublished\":\"2021-11-23T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\\\/\"},\"wordCount\":1481,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"zh-TW\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\\\/\",\"name\":\"CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2021-11-23T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\\\/#breadcrumb\"},\"inLanguage\":\"zh-TW\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-TW\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\",\"name\":\"admincg\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/tw\\\/author\\\/admincg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CENTOGENE\u64f4\u5927\u8207Agios\u7684\u5408\u4f5c\uff0c\u4ee5\u671f\u5728\u7f55\u898b\u8840\u6db2\u75be\u75c5\u9818\u57df\u7372\u5f97\u65b0\u7684\u898b\u89e3 | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/tw\/centogene\u64f4\u5927\u8207agios\u7684\u5408\u4f5c\uff0c\u4ee5\u671f\u5728\u7f55\u898b\u8840\u6db2\u75be\u75c5\u9818\u57df\u7372\u5f97\/","og_locale":"zh_TW","og_type":"article","og_title":"CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases | CENTOGENE","og_description":"CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, November 4, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company […]","og_url":"https:\/\/www.centogene.com\/tw\/centogene\u64f4\u5927\u8207agios\u7684\u5408\u4f5c\uff0c\u4ee5\u671f\u5728\u7f55\u898b\u8840\u6db2\u75be\u75c5\u9818\u57df\u7372\u5f97\/","og_site_name":"CENTOGENE","article_published_time":"2021-11-23T00:00:00+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"author":"admincg","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005:":"admincg","\u9810\u4f30\u95b1\u8b80\u6642\u9593":"7 \u5206\u9418"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.centogene.com\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/#article","isPartOf":{"@id":"https:\/\/www.centogene.com\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/"},"author":{"name":"admincg","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b"},"headline":"CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases","datePublished":"2021-11-23T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.centogene.com\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/"},"wordCount":1481,"commentCount":0,"publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"zh-TW","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.centogene.com\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/","url":"https:\/\/www.centogene.com\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/","name":"CENTOGENE\u64f4\u5927\u8207Agios\u7684\u5408\u4f5c\uff0c\u4ee5\u671f\u5728\u7f55\u898b\u8840\u6db2\u75be\u75c5\u9818\u57df\u7372\u5f97\u65b0\u7684\u898b\u89e3 | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2021-11-23T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/#breadcrumb"},"inLanguage":"zh-TW","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"\u4e2d\u5fc3\u57fa\u56e0","description":"\u5f15\u9818\u7cbe\u6e96\u91ab\u7642","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-TW"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"\u4e2d\u5fc3\u57fa\u56e0","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]},{"@type":"Person","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b","name":"\u7ba1\u7406\u54e1","url":"https:\/\/www.centogene.com\/tw\/author\/admincg\/"}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/posts\/2247","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/comments?post=2247"}],"version-history":[{"count":0,"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/posts\/2247\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/media?parent=2247"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/categories?post=2247"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/tags?post=2247"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}